Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03243630Phase 1Completed
Phase 1, randomised, double-blind trial of nicotine in nicotine dependence (3 arms), sponsored by Yale University. Primary endpoint: Drug Effects Questionnaire. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03243630.